Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene Elaparvovec.

Thromb Haemost · 2024 · PMC11436294 · PMID 38863155

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an apparent trendno p-value reported

There was an apparent trend to higher SynthASil to Actin FSL and SynthASil to Rox FIX ratios, with lower FIX activity values for both participant and control plasma samples.

also in 125 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.